Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

计划入组 12 人 · 首次发布于 2016 年 10 月 28 日

Growth and Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based Diet With Prolacta®

计划入组 196 人 · 首次发布于 2019 年 3 月 22 日

Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness

计划入组 72 人 · 首次发布于 2017 年 5 月 12 日

Epoetin alfa biosimilar (Siam Bioscience)

NIMA (Sprint Bioscience)

VADA (Sprint Bioscience)

Prolacta Bioscience, Inc.

United States

INFLECTIS BIOSCIENCE

France

Lexaria Bioscience

United States

Japan Grants World-First Pharmaceutical Approval for Human Milk-Based Fortifier in Neonatal Care

Skye Bioscience Advances Nimacimab into Phase 2 Obesity Trial

Daré Bioscience Advances Sildenafil Cream for Female Sexual Arousal Disorder